Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 69,400 shares at $0.27 ($19K) on 2022-10-27, disclosed to the SEC on 2022-10-31.
Seasonal purchase ($19k) by Chairman and CEO, 10% Owner — this insider has traded EMMA in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.22 | 7,500 | $2K | 8.6% |
| 2 | $0.26 | 20,000 | $5K | 27.0% |
| 3 | $0.27 | 11,900 | $3K | 16.7% |
| 4 | $0.27 | 22,500 | $6K | 31.5% |
| 5 | $0.42 | 7,500 | $3K | 16.3% |
| Total | $0.28 avg | 69,400 |
| $19K |
| 100% |
| Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |
| EMMA | BUY | 2022-10-17 | $17K | — | Filing → |